Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia D Wurster

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Neurological Disorders|March 24, 2018
Nusinersen for spinal muscular atrophyClaudia D Wurster, Albert C Ludolph
Current Opinion in Neurology|August 20, 2019
Therapeutic advances in SMAAlbert C Ludolph, Claudia D Wurster
Therapeutic Advances in Neurological Disorders|June 2, 2018
Antisense oligonucleotides in neurological disordersClaudia D Wurster, Albert C Ludolph
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|September 9, 2020
Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy - A pilot studyTeresa Kruse, Raoul Heller, Brunhilde Wirth, et al.
Fortschritte Der Neurologie-Psychiatrie|December 18, 2019
[Spinal Muscular Atrophy - expert recommendations for the use of nusinersen in adult patients]Tim Hagenacker, Andreas Hermann, Christoph Kamm, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Pain in adult and adolescent patients with 5q-associated Spinal Muscular Atrophy - an often underrated phenomenonLisa M Keipert, Claudia D Wurster, Zeljko Uzelac, et al.
Therapeutic Advances in Neurological Disorders|August 29, 2024
Pattern of pareses in 5q-spinal muscular atrophyZeljko Uzelac, Beate Schwäble, Johannes Dorst, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Frontiers in Neurology|January 1, 2024
Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|March 24, 2018
Nusinersen for spinal muscular atrophyClaudia D Wurster, Albert C Ludolph
Current Opinion in Neurology|August 20, 2019
Therapeutic advances in SMAAlbert C Ludolph, Claudia D Wurster
Therapeutic Advances in Neurological Disorders|June 2, 2018
Antisense oligonucleotides in neurological disordersClaudia D Wurster, Albert C Ludolph
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|September 9, 2020
Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy - A pilot studyTeresa Kruse, Raoul Heller, Brunhilde Wirth, et al.
Fortschritte Der Neurologie-Psychiatrie|December 18, 2019
[Spinal Muscular Atrophy - expert recommendations for the use of nusinersen in adult patients]Tim Hagenacker, Andreas Hermann, Christoph Kamm, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Pain in adult and adolescent patients with 5q-associated Spinal Muscular Atrophy - an often underrated phenomenonLisa M Keipert, Claudia D Wurster, Zeljko Uzelac, et al.
Therapeutic Advances in Neurological Disorders|August 29, 2024
Pattern of pareses in 5q-spinal muscular atrophyZeljko Uzelac, Beate Schwäble, Johannes Dorst, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Frontiers in Neurology|January 1, 2024
Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.
Pageof 3